Delivery Order SPE2DB20D2001-SPE2DB24FM46Y
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $2,854.28, is for the delivery of Bupropion HCL XL 300 mg tablets over the period ending on January 26, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025....
- This federal contract award, valued at $13,869.60, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Bupropion HCL XL 150 mg tablets in quantities of 500 tablets per bottle. This is a Firm Fixed Price Delivery Order contract with a completion date of February 8, 2024. The contract was awarded on February 7, 2024 and does not have a set-aside designation, indicating open...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,876.60, is for the delivery of Bupropion HCL XL 300 mg tablets and is a firm fixed-price delivery order with a completion date of May 1, 2024. The contract is not designated as a set-aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $25,866.44, is for the delivery of Bupropion HCL XL 150 mg tablets over a 2-year period ending in May 2024. Amerisourcebergen Drug Corp is the prime contractor, with no set-aside designation mentioned, indicating an open competition. The contract is structured as a Delivery Order under a larger Indefinite Delivery Contract (IDC) that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $28,325.23 firm fixed-price delivery order is for the supply of Bupropion HCL XL 300 mg tablets, with a completion date of February 23, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $63,780.64, for the supply of 4564416340 - Bupropion HCL XL 300 MG Tablets in quantities of 500s. The contract has an ultimate completion date of April 29, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $44,445.73, is for the procurement of Bupropion HCL XL 300 mg tablets, a medication used to treat depression and other conditions. The contract is a firm fixed-price delivery order with an ultimate completion date of April 26, 2024. The contract was awarded on April 25, 2024, and there was no set-aside used....
- This federal contract award, valued at $24,183.49, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) for the procurement of BUPROPION HCL XL 300 MG TABLET 500S, a pharmaceutical product. The contract has an ultimate completion date of February 29, 2024, and is a Firm Fixed Price type. This award is not designated as a set-aside...
- The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564034116 - Bupropion HCL XL 300 mg Tablets in 500 count packages. The contract has a ceiling value of $5,364.72 and a performance period through March 22, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a larger $999,999,999.00 indefinite delivery...
- This federal contract award, valued at $9,151.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a delivery order contract for the supply of BUPROPION HCL XL 300 MG TABLET 500S, with a completion date of February 13, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB24FM46YDelivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $34,961.14, is for the delivery of Bupropion HCL XL 300 mg tablets to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with a completion date of February 27, 2024. The contract was awarded on February 26, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, the prime contractor, is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, to provide a comprehensive range of pharmaceutical products and medical supplies to military and veteran healthcare facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.0k | 2/26/24 |